Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NT... AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Mehr anzeigen
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today...
Epetraborole-treated patients demonstrated clinical improvements in QOL-B and a post-hoc analysis of MACrO2 with nominal statistical significance when evaluated as continuous measures First drug...
Grant from the Bill & Melinda Gates Foundation AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.43 | 42.5742574257 | 1.01 | 1.46 | 0.975 | 2020275 | 1.17754873 | CS |
| 4 | 0.35 | 32.1100917431 | 1.09 | 1.46 | 0.975 | 764173 | 1.14076835 | CS |
| 12 | 0.33 | 29.7297297297 | 1.11 | 1.46 | 0.975 | 400130 | 1.11099507 | CS |
| 26 | -0.8 | -35.7142857143 | 2.24 | 3.07 | 0.87 | 473684 | 1.25483592 | CS |
| 52 | -14.69 | -91.0725356479 | 16.13 | 22.22 | 0.87 | 389662 | 3.06519056 | CS |
| 156 | -15.41 | -91.4540059347 | 16.85 | 23.58 | 0.87 | 184410 | 4.82781452 | CS |
| 260 | -15.41 | -91.4540059347 | 16.85 | 23.58 | 0.87 | 184410 | 4.82781452 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
